| Foresite Capital Management VI LLC | 10% owner | 2.28% | 2,908,332 | Jan 8, 2026 |
| Foresite Labs, LLC | 10% owner | 2.28% | 2,908,332 | Jan 8, 2026 |
| Tananbaum James B. | Director · 10% owner | 2.28% | 2,908,332 | Jan 8, 2026 |
| AKKARAJU SRINIVAS | Director | 1.45% | 1,853,488 | Jan 9, 2026 |
| Goldstein David M | Chief Scientific Officer | 0.00% | 0 | Jan 26, 2026 |
| Babler Martin | President, CEO and Chairman · Director | — | — | Jan 26, 2026 |
| Bradley Mark Christopher | Chief Development Officer | — | — | Jan 26, 2026 |
| Drappa Jorn | Chief Medical Officer | — | — | Jan 26, 2026 |
| Foresite Capital Fund VI LP | 10% owner | — | — | — |
| Foresite Capital Fund V, L.P. | 10% owner | — | — | — |
| Foresite Capital Management V, LLC | 10% owner | — | — | — |
| Foresite Capital Opportunity Fund V, L.P. | 10% owner | — | — | — |
| Foresite Capital Opportunity Management V, LLC | 10% owner | — | — | — |
| Foresite Labs Affiliates 2021, LLC | 10% owner | — | — | — |
| Foresite Labs Fund I, L.P. | 10% owner | — | — | — |
| Foresite Labs Management I, LLC | 10% owner | — | — | — |
| Hardiman Roy C. | Chief Business & Strategy Ofcr | — | — | Jan 26, 2026 |
| Labs Co-Invest V, LLC | 10% owner | — | — | — |
| Pangali Sanam | Chief Legal Officer | — | — | Jan 26, 2026 |
| Schroer John R. | Chief Financial Officer | — | — | Jan 26, 2026 |